BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 048224
(220 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|1A5J|A Chain A, Chicken B-Myb Dna Binding Domain, Repeat 2 And Repeat3,
Nmr, 32 Structures
Length = 110
Score = 54.3 bits (129), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 29/75 (38%), Positives = 41/75 (54%), Gaps = 5/75 (6%)
Query: 2 YGEGKWHQVPLRAGLNRCRKSCRLRWLNYLKPNIKRGEFVADEIDLMIRLHKLLGNRQEH 61
YG +W + + R K CR RW N+L P +K+ + +E ++ HK+LGNR
Sbjct: 25 YGTKQWTLIA-KHLKGRLGKQCRERWHNHLNPEVKKSSWTEEEDRIIFEAHKVLGNR--- 80
Query: 62 MWSLIAARLPGRTSN 76
W+ IA LPGRT N
Sbjct: 81 -WAEIAKLLPGRTDN 94
>pdb|1H8A|C Chain C, Crystal Structure Of Ternary Protein-Dna Complex3
Length = 128
Score = 53.1 bits (126), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 29/75 (38%), Positives = 41/75 (54%), Gaps = 5/75 (6%)
Query: 2 YGEGKWHQVPLRAGLNRCRKSCRLRWLNYLKPNIKRGEFVADEIDLMIRLHKLLGNRQEH 61
YG +W + + R K CR RW N+L P +K+ + +E ++ + HK LGNR
Sbjct: 45 YGPKRWSDIA-KHLKGRIGKQCRERWHNHLNPEVKKTSWTEEEDRIIYQAHKRLGNR--- 100
Query: 62 MWSLIAARLPGRTSN 76
W+ IA LPGRT N
Sbjct: 101 -WAEIAKLLPGRTDN 114
Score = 30.8 bits (68), Expect = 0.64, Method: Compositional matrix adjust.
Identities = 22/78 (28%), Positives = 34/78 (43%), Gaps = 10/78 (12%)
Query: 17 NRCRKSCRLRWLNYLKPNIKRGEFVADEIDLMIRLHKLLGNRQEHMWSLIAARLPGRTS- 75
NR C+ RW L P + +G + +E +I + G ++ WS IA L GR
Sbjct: 7 NRTDVQCQHRWQKVLNPELNKGPWTKEEDQRVIEHVQKYGPKR---WSDIAKHLKGRIGK 63
Query: 76 ------NDKLKPEAPKIA 87
++ L PE K +
Sbjct: 64 QCRERWHNHLNPEVKKTS 81
>pdb|1H88|C Chain C, Crystal Structure Of Ternary Protein-Dna Complex1
pdb|1H89|C Chain C, Crystal Structure Of Ternary Protein-Dna Complex2
Length = 159
Score = 52.8 bits (125), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 30/75 (40%), Positives = 41/75 (54%), Gaps = 5/75 (6%)
Query: 2 YGEGKWHQVPLRAGLNRCRKSCRLRWLNYLKPNIKRGEFVADEIDLMIRLHKLLGNRQEH 61
YG +W V + R K CR RW N+L P +K+ + +E ++ + HK LGNR
Sbjct: 76 YGPKRW-SVIAKHLKGRIGKQCRERWHNHLNPEVKKTSWTEEEDRIIYQAHKRLGNR--- 131
Query: 62 MWSLIAARLPGRTSN 76
W+ IA LPGRT N
Sbjct: 132 -WAEIAKLLPGRTDN 145
Score = 35.0 bits (79), Expect = 0.036, Method: Compositional matrix adjust.
Identities = 23/78 (29%), Positives = 37/78 (47%), Gaps = 10/78 (12%)
Query: 17 NRCRKSCRLRWLNYLKPNIKRGEFVADEIDLMIRLHKLLGNRQEHMWSLIAARLPGRTS- 75
NR C+ RW L P + +G + +E +I+L + G ++ WS+IA L GR
Sbjct: 38 NRTDVQCQHRWQKVLNPELIKGPWTKEEDQRVIKLVQKYGPKR---WSVIAKHLKGRIGK 94
Query: 76 ------NDKLKPEAPKIA 87
++ L PE K +
Sbjct: 95 QCRERWHNHLNPEVKKTS 112
>pdb|1GV2|A Chain A, Crystal Structure Of C-Myb R2r3
Length = 105
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 30/75 (40%), Positives = 41/75 (54%), Gaps = 5/75 (6%)
Query: 2 YGEGKWHQVPLRAGLNRCRKSCRLRWLNYLKPNIKRGEFVADEIDLMIRLHKLLGNRQEH 61
YG +W V + R K CR RW N+L P +K+ + +E ++ + HK LGNR
Sbjct: 22 YGPKRW-SVIAKHLKGRIGKQCRERWHNHLNPEVKKTSWTEEEDRIIYQAHKRLGNR--- 77
Query: 62 MWSLIAARLPGRTSN 76
W+ IA LPGRT N
Sbjct: 78 -WAEIAKLLPGRTDN 91
>pdb|1MSE|C Chain C, Solution Structure Of A Specific Dna Complex Of The Myb
Dna- Binding Domain With Cooperative Recognition
Helices
pdb|1MSF|C Chain C, Solution Structure Of A Specific Dna Complex Of The Myb
Dna- Binding Domain With Cooperative Recognition
Helices
Length = 105
Score = 52.4 bits (124), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 30/75 (40%), Positives = 41/75 (54%), Gaps = 5/75 (6%)
Query: 2 YGEGKWHQVPLRAGLNRCRKSCRLRWLNYLKPNIKRGEFVADEIDLMIRLHKLLGNRQEH 61
YG +W V + R K CR RW N+L P +K+ + +E ++ + HK LGNR
Sbjct: 22 YGPKRW-SVIAKHLKGRIGKQCRERWHNHLNPEVKKTSWTEEEDRIIYQAHKRLGNR--- 77
Query: 62 MWSLIAARLPGRTSN 76
W+ IA LPGRT N
Sbjct: 78 -WAEIAKLLPGRTDN 91
>pdb|3ZQC|A Chain A, Structure Of The Trichomonas Vaginalis Myb3 Dna-Binding
Domain Bound To A Promoter Sequence Reveals A Unique C-
Terminal Beta-Hairpin Conformation
pdb|3ZQC|D Chain D, Structure Of The Trichomonas Vaginalis Myb3 Dna-Binding
Domain Bound To A Promoter Sequence Reveals A Unique C-
Terminal Beta-Hairpin Conformation
pdb|3ZQC|G Chain G, Structure Of The Trichomonas Vaginalis Myb3 Dna-Binding
Domain Bound To A Promoter Sequence Reveals A Unique C-
Terminal Beta-Hairpin Conformation
pdb|3ZQC|J Chain J, Structure Of The Trichomonas Vaginalis Myb3 Dna-Binding
Domain Bound To A Promoter Sequence Reveals A Unique C-
Terminal Beta-Hairpin Conformation
Length = 131
Score = 47.0 bits (110), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 23/60 (38%), Positives = 35/60 (58%), Gaps = 4/60 (6%)
Query: 17 NRCRKSCRLRWLNYLKPNIKRGEFVADEIDLMIRLHKLLGNRQEHMWSLIAARLPGRTSN 76
NR K CR RW N+L P + + + +E + + R + LG++ WS+IA +PGRT N
Sbjct: 34 NRSPKQCRERWFNHLDPAVVKHAWTPEEDETIFRNYLKLGSK----WSVIAKLIPGRTDN 89
>pdb|3OSF|A Chain A, The Structure Of Protozoan Parasite Trichomonas
Vaginalis Myb2 In Complex With Mre-2f-13 Dna
pdb|3OSF|D Chain D, The Structure Of Protozoan Parasite Trichomonas
Vaginalis Myb2 In Complex With Mre-2f-13 Dna
pdb|3OSG|A Chain A, The Structure Of Protozoan Parasite Trichomonas
Vaginalis Myb2 In Complex With Mre-1-12 Dna
pdb|3OSG|D Chain D, The Structure Of Protozoan Parasite Trichomonas
Vaginalis Myb2 In Complex With Mre-1-12 Dna
Length = 126
Score = 43.9 bits (102), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 22/58 (37%), Positives = 33/58 (56%), Gaps = 4/58 (6%)
Query: 17 NRCRKSCRLRWLNYLKPNIKRGEFVADEIDLMIRLHKLLGNRQEHMWSLIAARLPGRT 74
NR + CR RW NYL P+I + A+E L+++ + G + W++IA PGRT
Sbjct: 42 NRNARQCRDRWKNYLAPSISHTPWTAEEDALLVQKIQEYGRQ----WAIIAKFFPGRT 95
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 33.5 bits (75), Expect = 0.095, Method: Compositional matrix adjust.
Identities = 22/62 (35%), Positives = 29/62 (46%), Gaps = 8/62 (12%)
Query: 36 KRGEFVAD-EIDLMIRLHKLLGNRQEHMWSLIAARLPGRTSNDKLKPEAPKIAKHNVIKP 94
+R F D EID + R+ + LG E +W PG TS KP PK A+ + K
Sbjct: 202 RRALFPGDSEIDQLFRIFRTLGTPDEVVW-------PGVTSMPDYKPSFPKWARQDFSKV 254
Query: 95 RP 96
P
Sbjct: 255 VP 256
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 33.5 bits (75), Expect = 0.097, Method: Compositional matrix adjust.
Identities = 22/62 (35%), Positives = 29/62 (46%), Gaps = 8/62 (12%)
Query: 36 KRGEFVAD-EIDLMIRLHKLLGNRQEHMWSLIAARLPGRTSNDKLKPEAPKIAKHNVIKP 94
+R F D EID + R+ + LG E +W PG TS KP PK A+ + K
Sbjct: 200 RRALFPGDSEIDQLFRIFRTLGTPDEVVW-------PGVTSMPDYKPSFPKWARQDFSKV 252
Query: 95 RP 96
P
Sbjct: 253 VP 254
>pdb|1IDY|A Chain A, Structure Of Myb Transforming Protein, Nmr, Minimized
Average Structure
pdb|1IDZ|A Chain A, Structure Of Myb Transforming Protein, Nmr, 20
Structures
Length = 54
Score = 33.5 bits (75), Expect = 0.097, Method: Compositional matrix adjust.
Identities = 17/42 (40%), Positives = 25/42 (59%), Gaps = 4/42 (9%)
Query: 35 IKRGEFVADEIDLMIRLHKLLGNRQEHMWSLIAARLPGRTSN 76
+K+ + +E ++ + HK LGNR W+ IA LPGRT N
Sbjct: 3 VKKTSWTEEEDRILYQAHKRLGNR----WAEIAKLLPGRTDN 40
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 33.5 bits (75), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 22/62 (35%), Positives = 29/62 (46%), Gaps = 8/62 (12%)
Query: 36 KRGEFVAD-EIDLMIRLHKLLGNRQEHMWSLIAARLPGRTSNDKLKPEAPKIAKHNVIKP 94
+R F D EID + R+ + LG E +W PG TS KP PK A+ + K
Sbjct: 203 RRALFPGDSEIDQLFRIFRTLGTPDEVVW-------PGVTSMPDYKPSFPKWARQDFSKV 255
Query: 95 RP 96
P
Sbjct: 256 VP 257
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 33.5 bits (75), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 22/62 (35%), Positives = 29/62 (46%), Gaps = 8/62 (12%)
Query: 36 KRGEFVAD-EIDLMIRLHKLLGNRQEHMWSLIAARLPGRTSNDKLKPEAPKIAKHNVIKP 94
+R F D EID + R+ + LG E +W PG TS KP PK A+ + K
Sbjct: 200 RRALFPGDSEIDQLFRIFRTLGTPDEVVW-------PGVTSMPDYKPSFPKWARQDFSKV 252
Query: 95 RP 96
P
Sbjct: 253 VP 254
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 33.5 bits (75), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 22/62 (35%), Positives = 29/62 (46%), Gaps = 8/62 (12%)
Query: 36 KRGEFVAD-EIDLMIRLHKLLGNRQEHMWSLIAARLPGRTSNDKLKPEAPKIAKHNVIKP 94
+R F D EID + R+ + LG E +W PG TS KP PK A+ + K
Sbjct: 199 RRALFPGDSEIDQLFRIFRTLGTPDEVVW-------PGVTSMPDYKPSFPKWARQDFSKV 251
Query: 95 RP 96
P
Sbjct: 252 VP 253
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 33.5 bits (75), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 22/62 (35%), Positives = 29/62 (46%), Gaps = 8/62 (12%)
Query: 36 KRGEFVAD-EIDLMIRLHKLLGNRQEHMWSLIAARLPGRTSNDKLKPEAPKIAKHNVIKP 94
+R F D EID + R+ + LG E +W PG TS KP PK A+ + K
Sbjct: 201 RRALFPGDSEIDQLFRIFRTLGTPDEVVW-------PGVTSMPDYKPSFPKWARQDFSKV 253
Query: 95 RP 96
P
Sbjct: 254 VP 255
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 33.5 bits (75), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 22/62 (35%), Positives = 29/62 (46%), Gaps = 8/62 (12%)
Query: 36 KRGEFVAD-EIDLMIRLHKLLGNRQEHMWSLIAARLPGRTSNDKLKPEAPKIAKHNVIKP 94
+R F D EID + R+ + LG E +W PG TS KP PK A+ + K
Sbjct: 203 RRALFPGDSEIDQLFRIFRTLGTPDEVVW-------PGVTSMPDYKPSFPKWARQDFSKV 255
Query: 95 RP 96
P
Sbjct: 256 VP 257
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 33.1 bits (74), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 22/62 (35%), Positives = 29/62 (46%), Gaps = 8/62 (12%)
Query: 36 KRGEFVAD-EIDLMIRLHKLLGNRQEHMWSLIAARLPGRTSNDKLKPEAPKIAKHNVIKP 94
+R F D EID + R+ + LG E +W PG TS KP PK A+ + K
Sbjct: 203 RRALFPGDSEIDQLFRIFRTLGTPDEVVW-------PGVTSMPDYKPSFPKWARQDFSKV 255
Query: 95 RP 96
P
Sbjct: 256 VP 257
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 33.1 bits (74), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 22/62 (35%), Positives = 29/62 (46%), Gaps = 8/62 (12%)
Query: 36 KRGEFVAD-EIDLMIRLHKLLGNRQEHMWSLIAARLPGRTSNDKLKPEAPKIAKHNVIKP 94
+R F D EID + R+ + LG E +W PG TS KP PK A+ + K
Sbjct: 200 RRALFPGDSEIDQLFRIFRTLGTPDEVVW-------PGVTSMPDYKPSFPKWARQDFSKV 252
Query: 95 RP 96
P
Sbjct: 253 VP 254
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 33.1 bits (74), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 22/62 (35%), Positives = 29/62 (46%), Gaps = 8/62 (12%)
Query: 36 KRGEFVAD-EIDLMIRLHKLLGNRQEHMWSLIAARLPGRTSNDKLKPEAPKIAKHNVIKP 94
+R F D EID + R+ + LG E +W PG TS KP PK A+ + K
Sbjct: 200 RRALFPGDSEIDQLFRIFRTLGTPDEVVW-------PGVTSMPDYKPSFPKWARQDFSKV 252
Query: 95 RP 96
P
Sbjct: 253 VP 254
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 33.1 bits (74), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 22/62 (35%), Positives = 29/62 (46%), Gaps = 8/62 (12%)
Query: 36 KRGEFVAD-EIDLMIRLHKLLGNRQEHMWSLIAARLPGRTSNDKLKPEAPKIAKHNVIKP 94
+R F D EID + R+ + LG E +W PG TS KP PK A+ + K
Sbjct: 200 RRALFPGDSEIDQLFRIFRTLGTPDEVVW-------PGVTSMPDYKPSFPKWARQDFSKV 252
Query: 95 RP 96
P
Sbjct: 253 VP 254
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 33.1 bits (74), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 22/62 (35%), Positives = 29/62 (46%), Gaps = 8/62 (12%)
Query: 36 KRGEFVAD-EIDLMIRLHKLLGNRQEHMWSLIAARLPGRTSNDKLKPEAPKIAKHNVIKP 94
+R F D EID + R+ + LG E +W PG TS KP PK A+ + K
Sbjct: 200 RRALFPGDSEIDQLFRIFRTLGTPDEVVW-------PGVTSMPDYKPSFPKWARQDFSKV 252
Query: 95 RP 96
P
Sbjct: 253 VP 254
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 33.1 bits (74), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 22/62 (35%), Positives = 29/62 (46%), Gaps = 8/62 (12%)
Query: 36 KRGEFVAD-EIDLMIRLHKLLGNRQEHMWSLIAARLPGRTSNDKLKPEAPKIAKHNVIKP 94
+R F D EID + R+ + LG E +W PG TS KP PK A+ + K
Sbjct: 200 RRALFPGDSEIDQLFRIFRTLGTPDEVVW-------PGVTSMPDYKPSFPKWARQDFSKV 252
Query: 95 RP 96
P
Sbjct: 253 VP 254
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 33.1 bits (74), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 22/62 (35%), Positives = 29/62 (46%), Gaps = 8/62 (12%)
Query: 36 KRGEFVAD-EIDLMIRLHKLLGNRQEHMWSLIAARLPGRTSNDKLKPEAPKIAKHNVIKP 94
+R F D EID + R+ + LG E +W PG TS KP PK A+ + K
Sbjct: 199 RRALFPGDSEIDQLFRIFRTLGTPDEVVW-------PGVTSMPDYKPSFPKWARQDFSKV 251
Query: 95 RP 96
P
Sbjct: 252 VP 253
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 33.1 bits (74), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 22/62 (35%), Positives = 29/62 (46%), Gaps = 8/62 (12%)
Query: 36 KRGEFVAD-EIDLMIRLHKLLGNRQEHMWSLIAARLPGRTSNDKLKPEAPKIAKHNVIKP 94
+R F D EID + R+ + LG E +W PG TS KP PK A+ + K
Sbjct: 201 RRALFPGDSEIDQLFRIFRTLGTPDEVVW-------PGVTSMPDYKPSFPKWARQDFSKV 253
Query: 95 RP 96
P
Sbjct: 254 VP 255
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 33.1 bits (74), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 22/62 (35%), Positives = 29/62 (46%), Gaps = 8/62 (12%)
Query: 36 KRGEFVAD-EIDLMIRLHKLLGNRQEHMWSLIAARLPGRTSNDKLKPEAPKIAKHNVIKP 94
+R F D EID + R+ + LG E +W PG TS KP PK A+ + K
Sbjct: 201 RRALFPGDSEIDQLFRIFRTLGTPDEVVW-------PGVTSMPDYKPSFPKWARQDFSKV 253
Query: 95 RP 96
P
Sbjct: 254 VP 255
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 33.1 bits (74), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 22/62 (35%), Positives = 29/62 (46%), Gaps = 8/62 (12%)
Query: 36 KRGEFVAD-EIDLMIRLHKLLGNRQEHMWSLIAARLPGRTSNDKLKPEAPKIAKHNVIKP 94
+R F D EID + R+ + LG E +W PG TS KP PK A+ + K
Sbjct: 203 RRALFPGDSEIDQLFRIFRTLGTPDEVVW-------PGVTSMPDYKPSFPKWARQDFSKV 255
Query: 95 RP 96
P
Sbjct: 256 VP 257
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 33.1 bits (74), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 22/62 (35%), Positives = 29/62 (46%), Gaps = 8/62 (12%)
Query: 36 KRGEFVAD-EIDLMIRLHKLLGNRQEHMWSLIAARLPGRTSNDKLKPEAPKIAKHNVIKP 94
+R F D EID + R+ + LG E +W PG TS KP PK A+ + K
Sbjct: 199 RRALFPGDSEIDQLFRIFRTLGTPDEVVW-------PGVTSMPDYKPSFPKWARQDFSKV 251
Query: 95 RP 96
P
Sbjct: 252 VP 253
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 33.1 bits (74), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 22/62 (35%), Positives = 29/62 (46%), Gaps = 8/62 (12%)
Query: 36 KRGEFVAD-EIDLMIRLHKLLGNRQEHMWSLIAARLPGRTSNDKLKPEAPKIAKHNVIKP 94
+R F D EID + R+ + LG E +W PG TS KP PK A+ + K
Sbjct: 202 RRALFPGDSEIDQLFRIFRTLGTPDEVVW-------PGVTSMPDYKPSFPKWARQDFSKV 254
Query: 95 RP 96
P
Sbjct: 255 VP 256
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 33.1 bits (74), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 22/62 (35%), Positives = 29/62 (46%), Gaps = 8/62 (12%)
Query: 36 KRGEFVAD-EIDLMIRLHKLLGNRQEHMWSLIAARLPGRTSNDKLKPEAPKIAKHNVIKP 94
+R F D EID + R+ + LG E +W PG TS KP PK A+ + K
Sbjct: 201 RRALFPGDSEIDQLFRIFRTLGTPDEVVW-------PGVTSMPDYKPSFPKWARQDFSKV 253
Query: 95 RP 96
P
Sbjct: 254 VP 255
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 33.1 bits (74), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 22/62 (35%), Positives = 29/62 (46%), Gaps = 8/62 (12%)
Query: 36 KRGEFVAD-EIDLMIRLHKLLGNRQEHMWSLIAARLPGRTSNDKLKPEAPKIAKHNVIKP 94
+R F D EID + R+ + LG E +W PG TS KP PK A+ + K
Sbjct: 199 RRALFPGDSEIDQLFRIFRTLGTPDEVVW-------PGVTSMPDYKPSFPKWARQDFSKV 251
Query: 95 RP 96
P
Sbjct: 252 VP 253
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 33.1 bits (74), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 22/62 (35%), Positives = 29/62 (46%), Gaps = 8/62 (12%)
Query: 36 KRGEFVAD-EIDLMIRLHKLLGNRQEHMWSLIAARLPGRTSNDKLKPEAPKIAKHNVIKP 94
+R F D EID + R+ + LG E +W PG TS KP PK A+ + K
Sbjct: 200 RRALFPGDSEIDQLFRIFRTLGTPDEVVW-------PGVTSMPDYKPSFPKWARQDFSKV 252
Query: 95 RP 96
P
Sbjct: 253 VP 254
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 33.1 bits (74), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 22/62 (35%), Positives = 29/62 (46%), Gaps = 8/62 (12%)
Query: 36 KRGEFVAD-EIDLMIRLHKLLGNRQEHMWSLIAARLPGRTSNDKLKPEAPKIAKHNVIKP 94
+R F D EID + R+ + LG E +W PG TS KP PK A+ + K
Sbjct: 200 RRALFPGDSEIDQLFRIFRTLGTPDEVVW-------PGVTSMPDYKPSFPKWARQDFSKV 252
Query: 95 RP 96
P
Sbjct: 253 VP 254
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 33.1 bits (74), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 22/62 (35%), Positives = 29/62 (46%), Gaps = 8/62 (12%)
Query: 36 KRGEFVAD-EIDLMIRLHKLLGNRQEHMWSLIAARLPGRTSNDKLKPEAPKIAKHNVIKP 94
+R F D EID + R+ + LG E +W PG TS KP PK A+ + K
Sbjct: 202 RRALFPGDSEIDQLFRIFRTLGTPDEVVW-------PGVTSMPDYKPSFPKWARQDFSKV 254
Query: 95 RP 96
P
Sbjct: 255 VP 256
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 33.1 bits (74), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 22/62 (35%), Positives = 29/62 (46%), Gaps = 8/62 (12%)
Query: 36 KRGEFVAD-EIDLMIRLHKLLGNRQEHMWSLIAARLPGRTSNDKLKPEAPKIAKHNVIKP 94
+R F D EID + R+ + LG E +W PG TS KP PK A+ + K
Sbjct: 203 RRALFPGDSEIDQLFRIFRTLGTPDEVVW-------PGVTSMPDYKPSFPKWARQDFSKV 255
Query: 95 RP 96
P
Sbjct: 256 VP 257
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 33.1 bits (74), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 22/62 (35%), Positives = 29/62 (46%), Gaps = 8/62 (12%)
Query: 36 KRGEFVAD-EIDLMIRLHKLLGNRQEHMWSLIAARLPGRTSNDKLKPEAPKIAKHNVIKP 94
+R F D EID + R+ + LG E +W PG TS KP PK A+ + K
Sbjct: 202 RRALFPGDSEIDQLFRIFRTLGTPDEVVW-------PGVTSMPDYKPSFPKWARQDFSKV 254
Query: 95 RP 96
P
Sbjct: 255 VP 256
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 33.1 bits (74), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 22/62 (35%), Positives = 29/62 (46%), Gaps = 8/62 (12%)
Query: 36 KRGEFVAD-EIDLMIRLHKLLGNRQEHMWSLIAARLPGRTSNDKLKPEAPKIAKHNVIKP 94
+R F D EID + R+ + LG E +W PG TS KP PK A+ + K
Sbjct: 203 RRALFPGDSEIDQLFRIFRTLGTPDEVVW-------PGVTSMPDYKPSFPKWARQDFSKV 255
Query: 95 RP 96
P
Sbjct: 256 VP 257
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 33.1 bits (74), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 22/62 (35%), Positives = 29/62 (46%), Gaps = 8/62 (12%)
Query: 36 KRGEFVAD-EIDLMIRLHKLLGNRQEHMWSLIAARLPGRTSNDKLKPEAPKIAKHNVIKP 94
+R F D EID + R+ + LG E +W PG TS KP PK A+ + K
Sbjct: 199 RRALFPGDSEIDQLFRIFRTLGTPDEVVW-------PGVTSMPDYKPSFPKWARQDFSKV 251
Query: 95 RP 96
P
Sbjct: 252 VP 253
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 33.1 bits (74), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 22/62 (35%), Positives = 29/62 (46%), Gaps = 8/62 (12%)
Query: 36 KRGEFVAD-EIDLMIRLHKLLGNRQEHMWSLIAARLPGRTSNDKLKPEAPKIAKHNVIKP 94
+R F D EID + R+ + LG E +W PG TS KP PK A+ + K
Sbjct: 199 RRALFPGDSEIDQLFRIFRTLGTPDEVVW-------PGVTSMPDYKPSFPKWARQDFSKV 251
Query: 95 RP 96
P
Sbjct: 252 VP 253
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 33.1 bits (74), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 22/62 (35%), Positives = 29/62 (46%), Gaps = 8/62 (12%)
Query: 36 KRGEFVAD-EIDLMIRLHKLLGNRQEHMWSLIAARLPGRTSNDKLKPEAPKIAKHNVIKP 94
+R F D EID + R+ + LG E +W PG TS KP PK A+ + K
Sbjct: 204 RRALFPGDSEIDQLFRIFRTLGTPDEVVW-------PGVTSMPDYKPSFPKWARQDFSKV 256
Query: 95 RP 96
P
Sbjct: 257 VP 258
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 33.1 bits (74), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 22/62 (35%), Positives = 29/62 (46%), Gaps = 8/62 (12%)
Query: 36 KRGEFVAD-EIDLMIRLHKLLGNRQEHMWSLIAARLPGRTSNDKLKPEAPKIAKHNVIKP 94
+R F D EID + R+ + LG E +W PG TS KP PK A+ + K
Sbjct: 201 RRALFPGDSEIDQLFRIFRTLGTPDEVVW-------PGVTSMPDYKPSFPKWARQDFSKV 253
Query: 95 RP 96
P
Sbjct: 254 VP 255
>pdb|1MBJ|A Chain A, Mouse C-Myb Dna-Binding Domain Repeat 3
pdb|1MBK|A Chain A, Mouse C-Myb Dna-Binding Domain Repeat 3
Length = 53
Score = 33.1 bits (74), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 17/42 (40%), Positives = 25/42 (59%), Gaps = 4/42 (9%)
Query: 35 IKRGEFVADEIDLMIRLHKLLGNRQEHMWSLIAARLPGRTSN 76
+K+ + +E ++ + HK LGNR W+ IA LPGRT N
Sbjct: 1 VKKTSWTEEEDRIIYQAHKRLGNR----WAEIAKLLPGRTDN 38
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 33.1 bits (74), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 22/62 (35%), Positives = 29/62 (46%), Gaps = 8/62 (12%)
Query: 36 KRGEFVAD-EIDLMIRLHKLLGNRQEHMWSLIAARLPGRTSNDKLKPEAPKIAKHNVIKP 94
+R F D EID + R+ + LG E +W PG TS KP PK A+ + K
Sbjct: 207 RRALFPGDSEIDQLFRIFRTLGTPDEVVW-------PGVTSMPDYKPSFPKWARQDFSKV 259
Query: 95 RP 96
P
Sbjct: 260 VP 261
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 33.1 bits (74), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 22/62 (35%), Positives = 29/62 (46%), Gaps = 8/62 (12%)
Query: 36 KRGEFVAD-EIDLMIRLHKLLGNRQEHMWSLIAARLPGRTSNDKLKPEAPKIAKHNVIKP 94
+R F D EID + R+ + LG E +W PG TS KP PK A+ + K
Sbjct: 207 RRALFPGDSEIDQLFRIFRTLGTPDEVVW-------PGVTSMPDYKPSFPKWARQDFSKV 259
Query: 95 RP 96
P
Sbjct: 260 VP 261
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 33.1 bits (74), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 22/62 (35%), Positives = 29/62 (46%), Gaps = 8/62 (12%)
Query: 36 KRGEFVAD-EIDLMIRLHKLLGNRQEHMWSLIAARLPGRTSNDKLKPEAPKIAKHNVIKP 94
+R F D EID + R+ + LG E +W PG TS KP PK A+ + K
Sbjct: 200 RRALFPGDSEIDQLFRIFRTLGTPDEVVW-------PGVTSMPDYKPSFPKWARQDFSKV 252
Query: 95 RP 96
P
Sbjct: 253 VP 254
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 33.1 bits (74), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 22/62 (35%), Positives = 29/62 (46%), Gaps = 8/62 (12%)
Query: 36 KRGEFVAD-EIDLMIRLHKLLGNRQEHMWSLIAARLPGRTSNDKLKPEAPKIAKHNVIKP 94
+R F D EID + R+ + LG E +W PG TS KP PK A+ + K
Sbjct: 204 RRALFPGDSEIDQLFRIFRTLGTPDEVVW-------PGVTSMPDYKPSFPKWARQDFSKV 256
Query: 95 RP 96
P
Sbjct: 257 VP 258
>pdb|2K9N|A Chain A, Solution Nmr Structure Of The R2r3 Dna Binding Domain Of
Myb1 Protein From Protozoan Parasite Trichomonas
Vaginalis
pdb|2KDZ|A Chain A, Structure Of The R2r3 Dna Binding Domain Of Myb1 Protein
From Protozoan Parasite Trichomonas Vaginalis In Complex
With Mre-1MRE-2r Dna
Length = 107
Score = 29.3 bits (64), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 22/88 (25%), Positives = 43/88 (48%), Gaps = 6/88 (6%)
Query: 2 YGEGKWHQVPLRAGLNRCRKSCRLRWLNYLKPNIKRGEFVADEIDLMIRLHKLLGNRQEH 61
YG W ++ + + R + CR RW NY+ P ++ + +E L+ + + G +
Sbjct: 19 YGAKDWIRIS-QLMITRNPRQCRERWNNYINPALRTDPWSPEEDMLLDQKYAEYGPK--- 74
Query: 62 MWSLIAARLPGRTSNDKLKPEAPKIAKH 89
W+ I+ L R+ N+ ++ IA+H
Sbjct: 75 -WNKISKFLKNRSDNN-IRNRWMMIARH 100
>pdb|2DIM|A Chain A, Solution Structure Of The Myb_dna-Binding Domain Of
Human Cell Division Cycle 5-Like Protein
Length = 70
Score = 29.3 bits (64), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 14/41 (34%), Positives = 24/41 (58%), Gaps = 5/41 (12%)
Query: 2 YGEGKWHQVPLRAGL--NRCRKSCRLRWLNYLKPNIKRGEF 40
YG+ +W ++ A L + K C+ RW +L P+IK+ E+
Sbjct: 27 YGKNQWSRI---ASLLHRKSAKQCKARWYEWLDPSIKKTEW 64
>pdb|1ZXQ|A Chain A, The Crystal Structure Of Icam-2
Length = 192
Score = 27.7 bits (60), Expect = 5.2, Method: Compositional matrix adjust.
Identities = 22/87 (25%), Positives = 35/87 (40%), Gaps = 8/87 (9%)
Query: 12 LRAGLNRCRKSCRLRWLNYLKPNIKRGEFVADEIDLMIRLHKLLGNRQEHMWSLIAARLP 71
L LN+ + +W +YL NI D +++ H +QE M S ++ P
Sbjct: 36 LETSLNKILLDEQAQWKHYLVSNISH--------DTVLQCHFTCSGKQESMNSNVSVYQP 87
Query: 72 GRTSNDKLKPEAPKIAKHNVIKPRPRT 98
R L+P + K I+ R T
Sbjct: 88 PRQVILTLQPTLVAVGKSFTIECRVPT 114
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.318 0.135 0.428
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 7,501,936
Number of Sequences: 62578
Number of extensions: 312826
Number of successful extensions: 721
Number of sequences better than 100.0: 48
Number of HSP's better than 100.0 without gapping: 8
Number of HSP's successfully gapped in prelim test: 40
Number of HSP's that attempted gapping in prelim test: 666
Number of HSP's gapped (non-prelim): 51
length of query: 220
length of database: 14,973,337
effective HSP length: 95
effective length of query: 125
effective length of database: 9,028,427
effective search space: 1128553375
effective search space used: 1128553375
T: 11
A: 40
X1: 16 ( 7.3 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.7 bits)
S2: 49 (23.5 bits)